Business Trends

Aug 14, 2018
By BioPharm International Editors
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
Aug 14, 2018
By BioPharm International Editors
Pharmaceutical scientist association announces upcoming term’s board of directors.
Aug 09, 2018
By BioPharm International Editors
The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.
Aug 01, 2018
BioPharm International
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
Jul 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
Jul 17, 2018
By BioPharm International Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 12, 2018
By BioPharm International Editors
CPhI Korea to feature zone for finished dosage formulation drug products.
Jul 11, 2018
By BioPharm International Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 09, 2018
By BioPharm International Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 01, 2018
BioPharm International
Biosimilars and biobetters face developmental challenges to achieving commercialization.
native1_300x100
lorem ipsum